Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Mandana Chitsazan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Obesity, Eicosanoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The National Heart, Lung, and Blood Institute (NHLBI), NHLBI NIH HHS, American Heart Association.
Abstract (Originalsprache)
Aims
The molecular pathways by which obesity contributes to systemic inflammation are unclear. Eicosanoids are bioactive lipids that govern the upstream initiation of pro‐ and anti‐inflammatory activity. We sought to investigate the association of eicosanoids with obesity, adiposity, and cardiometabolic traits.
Methods
We conducted a cross‐sectional analysis of the Multi‐Ethnic Study of Atherosclerosis (MESA) study with external validation in two community‐based cohorts: Framingham Heart Study and Atherosclerosis Risk in Communities Study. We measured 811 eicosanoids using a directed, non‐targeted mass spectrometry‐based platform and examined their associations with BMI and eight related adiposity and cardiometabolic traits using multivariable‐adjusted linear regression.
Results
Among 5101 MESA participants (mean age 63 years, 53% women), we found 255 eicosanoids and related metabolites associated with BMI (FDR q < 0.01 for all). Among these, 82 showed consistent associations across all three cohorts, including 18 metabolites with known identities: 9 were associated with lower BMI including docosahexaenoic acid derivative 19,20‐DiHDPA, arachidonic acid derivatives (20‐carboxy‐arachidonic acid, 5,6‐diHETrE, 14,15‐diHETrE, 15‐HpETE), and eicosapentaenoic acid derivative 5‐HpEPE. By contrast, 9 metabolites associated with higher BMI including hydroxyoctadecenoic acid (HOME), 11‐hydroxy‐9‐octadecenoic acid (11‐HOME), and adrenic acid. Many BMI‐associated metabolites overlapped with other adipose traits including 240 (94%) with waist circumference and 93 (36%) with visceral adipose tissue.
Conclusion
We identified 82 BMI‐associated eicosanoids, including docosanoids and arachidonic acid derivatives associated with lower BMI, while octadecanoids and adrenic acid derivatives were associated with higher BMI. Our findings highlight the role of bioactive lipids and specific pro‐ and anti‐inflammatory pathways that may underlie adverse cardiometabolic consequences of obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
- Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- CardioVascular Institute, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Universitätsmedizin-Charité, Berlin, Germany.
- Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Amanda L Grundmann, Elizabeth Selvin
Förderung
- The National Heart, Lung, and Blood Institute (NHLBI)
- NHLBI NIH HHS
- American Heart Association
- Deutscher Akademischer Austauschdienst
- Foundation for the National Institutes of Health
- NCATS NIH HHS
- NIEHS NIH HHS
- Deutsche Herzstiftung
Zitieren
APA
Chitsazan, M., Parekh, J. K., Grundmann, A. L., Lau, E. S., Alotaibi, M., Yu, B., Rebholz, C. M., Selvin, E., Allen, N. B., Allison, M. A., Jain, M., Cheng, S., & Ho, J. E. (2026). Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71269
Vancouver
Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, et al. Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71269
BibTeX
@article{Chitsazan2026,
author = {Chitsazan, Mandana and Parekh, Juhi K and Grundmann, Amanda L and Lau, Emily S and Alotaibi, Mona and Yu, Bing and Rebholz, Casey M and Selvin, Elizabeth and Allen, Norrina B and Allison, Matthew A and Jain, Mohit and Cheng, Susan and Ho, Jennifer E},
title = {Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71269}
}
EUVIMED